Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Argus Research analyst John Eade upgraded Moderna Inc (NASDAQ:MRNA) from Hold to Buy and announced a $180 price target. Moderna closed at $142.77 on Thursday. See how other analysts view this stock.
- Northland Capital Markets analyst Jeff Grampp upgraded Evolution Petroleum Corporation (AMEX:EPM) from Market Perform to Outperform and announced a $4 price target. Evolution Petroleum shares closed at $3.58 on Thursday. See how other analysts view this stock.
- CIBC analyst Robert Catellier upgraded Enbridge (TSX:ENB) from Neutral to Outperformer and raised the price target from C$77 to C$78. See how other analysts view this stock.
Considering buying MRNA stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment